Patents by Inventor Remi Forrat

Remi Forrat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine Compositions
    Publication number: 20190201517
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Application
    Filed: September 6, 2018
    Publication date: July 4, 2019
    Applicant: SANOFI PASTEUR
    Inventors: Alain Bouckenooghe, Remi Forrat, Jean Lang, Mélanie Saville, Nadia Tornieporth
  • Immunization compositions and methods
    Patent number: 10143741
    Abstract: The present invention provides methods and compositions to induce neutralizing antibodies in mammals to serotypes of dengue virus, measles virus, mumps virus, rubella and/or VZV virus.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: December 4, 2018
    Assignee: Sanofi Pasteur SA
    Inventors: Alain Bouckenooghe, Remi Forrat, Denis Crevat
  • VACCINE COMPOSITIONS
    Publication number: 20150196631
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Application
    Filed: July 24, 2013
    Publication date: July 16, 2015
    Applicant: Sanofi Pasteur
    Inventors: Alain Bouckenooghe, Remi Forrat, Jean Lang, Mélanie Saville, Nadia Tornieporth
  • Immunization Compositions and Methods
    Publication number: 20140220073
    Abstract: The present invention provides methods and compositions to induce neutralizing antibodies in mammals to serotypes of dengue virus, measles virus, mumps virus, rubella and/or VZV virus.
    Type: Application
    Filed: April 14, 2014
    Publication date: August 7, 2014
    Applicant: SANOFI PASTEUR SA
    Inventors: Alain BOUCKENOOGHE, Remi FORRAT, Denis CREVAT
  • Immunization compositions and methods
    Patent number: 8697353
    Abstract: The present invention provides methods and compositions to induce neutralizing antibodies in mammals to serotypes of dengue virus, measles virus, mumps virus, rubella and/or VZV virus.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: April 15, 2014
    Assignee: Sanofi Pasteur SA
    Inventors: Alain Bouckenooghe, Remi Forrat, Denis Crevat
  • Immunization Compositions and Methods
    Publication number: 20110189226
    Abstract: The present invention provides methods and compositions to induce neutralizing antibodies in mammals to serotypes of dengue virus, measles virus, mumps virus, rubella and/or VZV virus.
    Type: Application
    Filed: February 1, 2011
    Publication date: August 4, 2011
    Applicant: SANOFI PASTEUR
    Inventors: Alain Bouckenooghe, Rémi Forrat, Denis Crevat
  • Method of Immunization Against the 4 Dengue Serotypes
    Publication number: 20100270202
    Abstract: The invention relates to a method for inducing a protection against the 4 dengue serotypes in a patient, comprising (a) a first series of administrations (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, and (b) a second series of administrations of doses (i) and (ii), in which the doses (i) and (ii) are administered simultaneously at separate anatomical sites, and in which the second series (b) is implemented at least 30 days to at most 12 months after the first series (a).
    Type: Application
    Filed: March 5, 2010
    Publication date: October 28, 2010
    Applicant: SANOFI PASTEUR SA
    Inventors: Bruno Guy, Rémi Forrat, Jean Lang, Véronique Barban
  • Method of Immunization Against the 4 Serotypes of Dengue Fever
    Publication number: 20100239612
    Abstract: The invention relates to a method for inducing protection against the 4 serotypes of dengue fever in a patient, comprising: (a) the administration of a monovalent vaccine comprising a vaccinal virus of a first serotype of dengue fever, and (b) the administration of a tetravalent vaccine comprising vaccinal viruses of the four serotypes of dengue fever, in which administration (b) is made between at least 30 days and not more than 12 months following the first administration (a).
    Type: Application
    Filed: March 5, 2010
    Publication date: September 23, 2010
    Applicant: SANOFI PASTEUR SA
    Inventors: Bruno Guy, Veronique Barban, Remi Forrat, Jean Lang
  • Method of Immunization Against the 4 Dengue Serotypes
    Publication number: 20100221285
    Abstract: The invention relates to a method for inducing a homologous protection against the 4 dengue serotypes in a patient, comprising the sequential administration, to said patient, (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, in which the vaccinal dengue viruses (ii) are administered at least 30 days and at most 1 year after administration of the vaccinal viruses (i).
    Type: Application
    Filed: March 5, 2010
    Publication date: September 2, 2010
    Applicant: SANOFI PASTEUR SA
    Inventors: Véronique Barban, Rémi Forrat, Bruno Guy, Jean Lang
  • Method of immunization against the 4 dengue serotypes
    Patent number: 7718358
    Abstract: The invention relates to a method for inducing a protection against the 4 dengue serotypes in a patient, comprising (a) a first series of administrations (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, and (b) a second series of administrations of doses (i) and (ii), in which the doses (i) and (ii) are administered simultaneously at separate anatomical sites, and in which the second series (b) is implemented at least 30 days to at most 12 months after the first series (a).
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: May 18, 2010
    Assignee: Sanofi Pasteur SA
    Inventors: Bruno Guy, Remi Forrat, Jean Lang, Veronique Barban
  • Method of immunization against the 4 serotypes of dengue fever
    Patent number: 7718359
    Abstract: The invention relates to a method for inducing protection against the 4 serotypes of dengue fever in a patient, comprising: (a) the administration of a monovalent vaccine comprising a vaccinal virus of a first serotype of dengue fever, and (b) the administration of a tetravalent vaccine comprising vaccinal viruses of the four serotypes of dengue fever, in which administration (b) is made between at least 30 days and not more than 12 months following the first administration (a).
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: May 18, 2010
    Assignee: Sanofi Pasteur SA
    Inventors: Bruno Guy, Veronique Barban, Remi Forrat, Jean Lang
  • Method of immunization against the 4 dengue serotypes
    Patent number: 7718357
    Abstract: The invention relates to a method for inducing a homologous protection against the 4 dengue serotypes in a patient, comprising the sequential administration, to said patient, (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, in which the vaccinal dengue viruses (ii) are administered at least 30 days and at most 1 year after administration of the vaccinal viruses (i).
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: May 18, 2010
    Assignee: Sanofi Pasteur SA
    Inventors: Bruno Guy, Véronique Barban, Rémi Forrat, Jean Lang
  • Vaccination Against Dengue Virus Infection
    Publication number: 20080193477
    Abstract: This invention relates to methods and kits for use in vaccination against dengue virus infection.
    Type: Application
    Filed: August 9, 2006
    Publication date: August 14, 2008
    Applicants: Acambis Inc., Sanofi Pasteur SA
    Inventors: Thomas P. Monath, Farshad Guirakhoo, Niranjan Kanesa-thasan, Thomas H. Ermak, Jean Lang, Remi Forrat
  • Method of Immunization Against the 4 Serotypes of Dengue Fever
    Publication number: 20080131460
    Abstract: The invention relates to a method for inducing protection against the 4 serotypes of dengue fever in a patient, comprising: (a) the administration of a monovalent vaccine comprising a vaccinal virus of a first serotype of dengue fever, and (b) the administration of a tetravalent vaccine comprising vaccinal viruses of the four serotypes of dengue fever, in which administration (b) is made between at least 30 days and not more than 12 months following the first administration (a).
    Type: Application
    Filed: November 21, 2007
    Publication date: June 5, 2008
    Applicant: SANOFI PASTEUR SA
    Inventors: Bruno GUY, Veronique BARBAN, Remi FORRAT, Jean LANG
  • Method of Immunization Against The 4 Dengue Serotypes
    Publication number: 20080085288
    Abstract: The invention relates to a method for inducing a protection against the 4 dengue serotypes in a patient, comprising (a) a first series of administrations (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, and (b) a second series of administrations of doses (i) and (ii), in which the doses (i) and (ii) are administered simultaneously at separate anatomical sites, and in which the second series (b) is implemented at least 30 days to at most 12 months after the first series (a).
    Type: Application
    Filed: October 2, 2007
    Publication date: April 10, 2008
    Applicant: SANOFI PASTEUR SA
    Inventors: Bruno Guy, Remi Forrat, Jean Lang, Veronique Barban
  • METHOD OF IMMUNIZATION AGAINST THE 4 DENGUE SEROTYPES
    Publication number: 20080014219
    Abstract: The invention relates to a method for inducing a homologous protection against the 4 dengue serotypes in a patient, comprising the sequential administration, to said patient, (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, in which the vaccinal dengue viruses (ii) are administered at least 30 days and at most 1 year after administration of the vaccinal viruses (i).
    Type: Application
    Filed: July 12, 2007
    Publication date: January 17, 2008
    Applicant: SANOFI PASTEUR
    Inventors: Veronique Barban, Remi Forrat, Bruno Guy, Jean Lang